Publications
3 shownAdjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Among patients with resected esophageal or gastroesophageal junction cancer who had received neoadjuvant chemoradiotherapy, disease-free survival was significantly longer among ...
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Gastric cancer is the third leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic l...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 5,693
- Institution
- The University of Texas MD Anderson Cancer Center
External Links
Identifiers
- ORCID
- 0000-0001-9946-0629
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.